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Background: Several international surveys have reported low levels of asthma
control compared to the levels set by the Global Initiative for Asthma guidelines.
Methods: In Turkey, 8350 households were surveyed and 400 current asthmatics
responded a structured questionnaire on symptom severity, activity limitations and
disease management.
Results: Most of the 55 children and 345 adults were classified as having persistent
asthma (72.7% and 88.1%, respectively). In adult asthmatics, 31.3% reported current
cigarette smoking and 10.7% being former smokers. Guideline-based asthma control
was achieved in only 1.3% of participants. Three-quarters of children and more than
90% of adults were experiencing daytime symptoms. Most of adult patients and
children reported an unfavorable impact of asthma on their social lives, and only half
had ever had a lung function test. Daily anti-inflammatory therapy, including inhaled
corticosteroids, was low in patients with persistent disease. Patients underestimated
their disease severity and overestimated their level of disease control.
Conclusions: The low level of asthma control in this Turkish population, together
with the underestimation of disease severity and control by the patients, high
smoking rates and low level of preventive medicine usage indicate a need for better
implementation of current guidelines and patient education on asthma in Turkey.
& 2006 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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During the last decades, many attempts have been
made to improve asthma-care including prepara-
tion and distribution of guidelines.1 It is obvious
that even good guidelines have no impact in clinical
practice unless they are implemented to daily
practice. Recently, the Asthma Insights and Reality
(AIR) surveys were conducted in order to test
asthma control levels set by the guidelines, in the
US, Europe, Asia-Pacific, Japan and Latin America
populations.2–6 Unfortunately, these surveys con-
sistently demonstrated a low level of asthma
control and overestimation of self-perceived asth-
ma control level.7
Turkey is situated between Europe and Asia
within the Balkan and Middle East regions and has
comparable prevalence of current asthma-symp-
toms among adults and children compared to
European countries, but a low rate of diagnosis
and treatment of asthma.8,9
In this study, using the methodology of AIR
surveys, we aimed to investigate current level of
guideline-based asthma control, patient’s percep-
tion of disease control and severity, and utilization
of effective asthma treatments in a Turkish
population.Methods
The survey was conducted with a methodology
similar to the previous AIR surveys7 and a repre-
sentative, urban population from 15 different cities
was screened.
Selection of participants
The designated respondents were assured of the
voluntary nature of the survey and the confidenti-
ality of all responses, and consent was obtained.
Because this survey was non-interventional, no
ethics committee approval was required.
Current asthmatic patients were defined as
patients with a physician’s diagnosis of asthma
and who were currently taking asthma medication
or had asthma attacks and symptoms during the
past 12 months. Sampling was done by random
door-to-door recruitment and an adult representa-
tive of each household was asked for the presence
of a current asthmatic fulfilling the case study
definition. In case of the presence of an asthma
patient, a face-to-face interview was done with the
patient or with a parent/guardian if the patient
was younger than 16 years. Where more than oneeligible case was identified in the same household,
one of them was randomly selected. Recruitment
continued until the required number of asthmatic
patients with a valid interview was achieved in
each area, resulting in a total sample of 400
asthmatic patients.
Questionnaire and interviews
The questionnaire was the translated Turkish
version of the English questionnaire used in the
Asthma Insights and Reality in Europe (AIRE)
survey.2 Respondents were questioned on asthma
symptoms, medications, healthcare utilization,
activity limitation due to asthma, and their
perception of asthma control and severity. Ques-
tions were asked verbally and visual cards display-
ing the alternative answers for selection were used
whenever appropriate.
Analysis and management of data
Patients were classified as having mild intermit-
tent, mild persistent, moderate persistent or
severe persistent disease by using a combined
symptom severity index which was previously
described elsewhere.7 Data are presented as
percentages and for quantitative variables, as
means with standard deviations.Results
Sample population
Overall, from 8530 households, at least one
asthmatic patient was identified in 495 (5.8%) and
valid interviews were performed by 400 (80.8%) of
the respondents. Reasons for failure were either
refusal or unavailability of a person for the inter-
view. Fourteen percent of the study population
(n ¼ 55) consisted of children, and they were
mostly represented by their mother.
A female predominance (73.3%) was observed for
adult patients (49.0715.7 year), whereas an al-
most equal sex distribution (female 54.5%) was
seen among children (7.173.3 year). When symp-
tom severity calculated by the asthma symptom
severity index was assessed, 72.7% of the children
and 88.1% of adults had persistent disease (mild
34.5% and 19.4%, moderate 12.7% and 28.4%,
severe 25.5% and 40.3%; respectively). Almost one
third (31.3%) of adult asthmatics were current
smokers and an additional 10.7% were former
smokers.
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Considering the GINA criteria for asthma control,
only 5 adults (1.25%) were able to meet all GINA
criteria of asthma control. Three-quarters of
children and 93.6% of adults were experiencing
daytime symptoms during the last 4 weeks and two
thirds of both children and adults were having night
awakenings. In almost half of adults and children,
sleep was disrupted at least once a week. Half of
children (50.9%) and 69.0% of adults had exercise-
induced asthma during the previous 12 months.
When emergency visits due to asthma were
considered, almost half of patients (56.4% of
children, 46.1% of adults) required an urgent/
emergency visit and almost 60% of both children
and adults required a quick relief prescription
medicine during the last month.
Although GINA guidelines recommend no limita-
tion of activities, social life was affected in almost
three-quarter of children and adult asthmatics. The
only exceptions to this were few limitations on
choice of jobs/career and school/work absence,
which were observed in less than half of the
patients, and work absence reported in 10% of
adults. Only about half of our patients had ever a
lung function test, and only around 1 in 5 patients
had a peak flow meter.
Only 37.5% of children and 30.3% of adults with
persistent disease were using daily preventative
drugs. Of these, 90% of adults and 22% of children
were current users of inhaled corticosteroids.
Patients’ perception of asthma
A discrepancy was found between symptom-based
severity of asthma and patients’ perception ofFigure 1 Patient/guardian perception of asthma coseverity (Figs. 1 and 2). Among patients with severe
or moderate persistent asthma, 45% believed that
they had either mild symptoms or no symptoms. A
similar discrepancy was demonstrated for calcu-
lated asthma severity and patients’ perception of
asthma control level. Although guideline-based
asthma control was achieved in only 1.3% of
patients, actually 45% believed that their disease
was either completely controlled or well con-
trolled. When patients with moderate or severe
asthma were considered, only 27.5% reported that
their asthma was either poorly controlled or not
controlled at all.Discussion
The AIRET survey demonstrated a low level of
asthma control in a representative sample of the
urban Turkish population, which is far below levels
recommended in GINA. AIRET is the first asthma
study of this type conducted in Turkey and provided
insights regarding the current management and
future requirements of asthmatic patients in
the area.
Several limitations of this study may be high-
lighted. Perhaps one of the most relevant is the
inclusion of patients exclusively from urban areas.
Considering the low level of healthcare facilities,
education and socioeconomic status, inclusion of
rural areas would possibly result in further lower
level of asthma control and healthcare utilization.
Another remarkable finding of the study was a
tendency to a more severe disease compared to
other AIR survey populations.7 About three-quar-
ters of our children and adults had persistent
disease, whereas it was only around half of thentrol level by symptom-based asthma severity.
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Figure 2 Patient/guardian perception of asthma severity by symptom-based asthma severity.
The AIRET study 1853asthma population in the US, Europe, Japan and
Asia-Pacific.2–7 One possible explanation may be
the methodology of the survey. Except in certain
Asia-Pacific populations,3 previous AIR surveys used
telephone interviews7 and AIRET used door-to-door
recruitment and visual cards to aid accurate
responses. Therefore the drug information data is
likely more valid in AIRET than in previous AIR
studies.
Patients in the AIRET survey suggest a group with
more severe disease. This is also reflected by a low
level of asthma control and a higher effect on social
life, compared to other AIR survey populations.
Guideline-based control was achieved in only 1.3%
of cases in the present study, where the corre-
sponding figure for AIRE was 5.3%; both are
extremely low when the availability of effective
treatments is taken into account. In the AIRE2 and
Asia-Pacific3 studies approximately half of adult
patients reported daytime symptoms, whereas it
was 90% in the present study. Night awakenings
were also more frequent compared to other
surveys.7 Another striking finding is the activity
limitation experienced by about 80% of partici-
pants. On the contrary, the effect on school and
work absence seems relatively lesser, which may be
partly due to unemployment or underestimation of
disease severity by the society and institutions.
Finally, the adult asthmatics in AIRET reported a
striking 31.3% of current smoking plus 10.7% of
former smoking, which may contribute further to
the lower level of disease control. This is by far the
highest smoking rates reported in any AIR study to
date,7 and a call for public health action.
Daily use of anti-inflammatory therapy is recom-
mended for patients with persistent asthma.1 In the
present study around one-third of patients withpersistent asthma were currently on daily preven-
tive anti-inflammatory therapy, and more than half
of these were using inhaled corticosteroids.
Although figures are well comparable or even
higher than reported in other AIR survey popula-
tions,7 many patients are still lacking the benefits
of an effective treatment. A recently published
study, the Gaining Optimal Asthma Control (GOAL)
study demonstrated that a strict control level (total
controlled) could be achieved in substantial pro-
portion of patients treated with salmeterol/fluti-
casone or fluticasone (41% and 28%, respectively).10
When guideline-based control (well controlled) was
considered, the proportion of patients further
increased approaching to 71% and 59%, respec-
tively. In AIRET, despite a quantifiable low level of
disease control, most patients overestimated their
level of control and underestimated disease sever-
ity. This is a finding consistent with previous reports
and seems to be largely due to adaptation to
symptoms and lifetime limitations, and lack of
awareness and low expectations of what can be
achieved by using currently available treatments.
The AIRET results and conclusions are partly
supported by data from two other Turkish surveys.
In the CAPTURE study11 where 756 asthmatic
children and adolescents were surveyed, almost
50% reported symptoms at least once a week and
only one third were on preventive medication. The
second survey focused on asthma-related knowl-
edge and attitude of Turkish physicians treating
asthmatic children12 and showed that assessment
of asthma severity was the least understood part of
the guidelines and a low utilization of lung function
tests. Consistent with our findings, both studies
pointed out the inadequate treatment of asthma as
a common problem.
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other international AIR surveys, demonstrated a
low level of asthma control among asthmatics in
Turkey, despite the availability of effective thera-
pies. Low usage of preventive medicine and low
expectations of what can be achieved by effective
treatments seem to be the main causes. Better
implementation of asthma management guidelines,
patient education to raise awareness and expecta-
tions, and more vigorous programs to quit smoking
are warranted to improve asthma outcomes in
Turkey.Acknowledgements
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